Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.3800
0.00 (0.00%)
At close: Jan 12, 2026
Nika Pharmaceuticals Statistics
Total Valuation
NIKA has a market cap or net worth of 395.06 million. The enterprise value is 395.34 million.
| Market Cap | 395.06M |
| Enterprise Value | 395.34M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NIKA has 1.04 billion shares outstanding. The number of shares has increased by 5.56% in one year.
| Current Share Class | 1.04B |
| Shares Outstanding | 1.04B |
| Shares Change (YoY) | +5.56% |
| Shares Change (QoQ) | +1.31% |
| Owned by Insiders (%) | 60.13% |
| Owned by Institutions (%) | 14.86% |
| Float | 264.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1,516.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7,637.82 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -258.70% |
| Return on Invested Capital (ROIC) | -258.70% |
| Return on Capital Employed (ROCE) | 19.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.59% in the last 52 weeks. The beta is -0.69, so NIKA's price volatility has been lower than the market average.
| Beta (5Y) | -0.69 |
| 52-Week Price Change | -35.59% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.33 |
| Average Volume (20 Days) | 6,238 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -51,762 |
| Pretax Income | -51,761 |
| Net Income | -51,761 |
| EBITDA | n/a |
| EBIT | -51,762 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 6,287 in cash and 284,164 in debt, with a net cash position of -277,877 or -0.00 per share.
| Cash & Cash Equivalents | 6,287 |
| Total Debt | 284,164 |
| Net Cash | -277,877 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -260,539 |
| Book Value Per Share | -0.00 |
| Working Capital | -260,539 |
Cash Flow
| Operating Cash Flow | -69,099 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NIKA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.56% |
| Shareholder Yield | -5.56% |
| Earnings Yield | -0.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |